The in vitro effects of selenomethionine on methylmercury-induced neurotoxicity

Parvinder Kaur, Lars Evje, Michael Aschner, Tore Syversen

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Selenium (Se) has been reported to reduce the severity of MeHg-induced neurological deficits. Therefore, we investigated whether 24 h. preincubation or 50 min. coincubation with selenomethionine (SeMet) was effective in reducing methylmercury (MeHg)-induced cytotoxicity in C6-glioma and B35-neuronal cell lines. As indicators of cytotoxicity, reduced glutathione (GSH), reactive oxygen species (ROS) and mitochondrial activity (MTT) was assessed. Measurement of GSH with the fluorescent indicator MCB-monochlorobimane indicated that in SeMet preincubated C6 cells, MeHg treatment resulted in a significant (p < 0.001) decrease in GSH levels as compared to coincubation group. Treatment with SeMet did not induce any significant changes in MTT activity in either of the cell lines as compared to the MeHg group. However, the amount of MeHg-induced ROS was significantly reduced (p < 0.001) after SeMet preincubation in both the cell lines. The intracellular Se content was measured with high resolution-inductively coupled plasma mass spectrometry (HR-ICPMS). In both the cell lines the intracellular Se levels increased after pre- and coincubation with 20 and 50 μM SeMet. However, the preincubation group exhibited increased Se content in both the cell lines and varied (p < 0.001) from coincubation group. These differences in the Se content were maintained after 10 μM MeHg treatment for 50 min. In C6-gliomas, the cell associated-MeHg measurements using 14C-labeled MeHg indicated a significant increase (p < 0.001) in MeHg content in preincubated cells as compared to coincubated cells. These findings provide experimental evidence that preincubation with SeMet increases Se content in cells and prevents against increased MeHg-induced ROS generation.

Original languageEnglish (US)
Pages (from-to)378-385
Number of pages8
JournalToxicology in Vitro
Volume23
Issue number3
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Selenomethionine
Selenium
Cells
Cell Line
Reactive Oxygen Species
Cytotoxicity
Glioma
Inductively coupled plasma mass spectrometry
Glutathione
In Vitro Techniques
Mass Spectrometry

Keywords

  • Cell cultures
  • In vitro
  • Neurotoxicity
  • Reactive oxygen species
  • Reduced glutathione
  • Selenomethionine

ASJC Scopus subject areas

  • Toxicology

Cite this

The in vitro effects of selenomethionine on methylmercury-induced neurotoxicity. / Kaur, Parvinder; Evje, Lars; Aschner, Michael; Syversen, Tore.

In: Toxicology in Vitro, Vol. 23, No. 3, 04.2009, p. 378-385.

Research output: Contribution to journalArticle

Kaur, Parvinder ; Evje, Lars ; Aschner, Michael ; Syversen, Tore. / The in vitro effects of selenomethionine on methylmercury-induced neurotoxicity. In: Toxicology in Vitro. 2009 ; Vol. 23, No. 3. pp. 378-385.
@article{8a83185e8cff4a47850131edf6bb89be,
title = "The in vitro effects of selenomethionine on methylmercury-induced neurotoxicity",
abstract = "Selenium (Se) has been reported to reduce the severity of MeHg-induced neurological deficits. Therefore, we investigated whether 24 h. preincubation or 50 min. coincubation with selenomethionine (SeMet) was effective in reducing methylmercury (MeHg)-induced cytotoxicity in C6-glioma and B35-neuronal cell lines. As indicators of cytotoxicity, reduced glutathione (GSH), reactive oxygen species (ROS) and mitochondrial activity (MTT) was assessed. Measurement of GSH with the fluorescent indicator MCB-monochlorobimane indicated that in SeMet preincubated C6 cells, MeHg treatment resulted in a significant (p < 0.001) decrease in GSH levels as compared to coincubation group. Treatment with SeMet did not induce any significant changes in MTT activity in either of the cell lines as compared to the MeHg group. However, the amount of MeHg-induced ROS was significantly reduced (p < 0.001) after SeMet preincubation in both the cell lines. The intracellular Se content was measured with high resolution-inductively coupled plasma mass spectrometry (HR-ICPMS). In both the cell lines the intracellular Se levels increased after pre- and coincubation with 20 and 50 μM SeMet. However, the preincubation group exhibited increased Se content in both the cell lines and varied (p < 0.001) from coincubation group. These differences in the Se content were maintained after 10 μM MeHg treatment for 50 min. In C6-gliomas, the cell associated-MeHg measurements using 14C-labeled MeHg indicated a significant increase (p < 0.001) in MeHg content in preincubated cells as compared to coincubated cells. These findings provide experimental evidence that preincubation with SeMet increases Se content in cells and prevents against increased MeHg-induced ROS generation.",
keywords = "Cell cultures, In vitro, Neurotoxicity, Reactive oxygen species, Reduced glutathione, Selenomethionine",
author = "Parvinder Kaur and Lars Evje and Michael Aschner and Tore Syversen",
year = "2009",
month = "4",
doi = "10.1016/j.tiv.2008.12.024",
language = "English (US)",
volume = "23",
pages = "378--385",
journal = "Toxicology in Vitro",
issn = "0887-2333",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - The in vitro effects of selenomethionine on methylmercury-induced neurotoxicity

AU - Kaur, Parvinder

AU - Evje, Lars

AU - Aschner, Michael

AU - Syversen, Tore

PY - 2009/4

Y1 - 2009/4

N2 - Selenium (Se) has been reported to reduce the severity of MeHg-induced neurological deficits. Therefore, we investigated whether 24 h. preincubation or 50 min. coincubation with selenomethionine (SeMet) was effective in reducing methylmercury (MeHg)-induced cytotoxicity in C6-glioma and B35-neuronal cell lines. As indicators of cytotoxicity, reduced glutathione (GSH), reactive oxygen species (ROS) and mitochondrial activity (MTT) was assessed. Measurement of GSH with the fluorescent indicator MCB-monochlorobimane indicated that in SeMet preincubated C6 cells, MeHg treatment resulted in a significant (p < 0.001) decrease in GSH levels as compared to coincubation group. Treatment with SeMet did not induce any significant changes in MTT activity in either of the cell lines as compared to the MeHg group. However, the amount of MeHg-induced ROS was significantly reduced (p < 0.001) after SeMet preincubation in both the cell lines. The intracellular Se content was measured with high resolution-inductively coupled plasma mass spectrometry (HR-ICPMS). In both the cell lines the intracellular Se levels increased after pre- and coincubation with 20 and 50 μM SeMet. However, the preincubation group exhibited increased Se content in both the cell lines and varied (p < 0.001) from coincubation group. These differences in the Se content were maintained after 10 μM MeHg treatment for 50 min. In C6-gliomas, the cell associated-MeHg measurements using 14C-labeled MeHg indicated a significant increase (p < 0.001) in MeHg content in preincubated cells as compared to coincubated cells. These findings provide experimental evidence that preincubation with SeMet increases Se content in cells and prevents against increased MeHg-induced ROS generation.

AB - Selenium (Se) has been reported to reduce the severity of MeHg-induced neurological deficits. Therefore, we investigated whether 24 h. preincubation or 50 min. coincubation with selenomethionine (SeMet) was effective in reducing methylmercury (MeHg)-induced cytotoxicity in C6-glioma and B35-neuronal cell lines. As indicators of cytotoxicity, reduced glutathione (GSH), reactive oxygen species (ROS) and mitochondrial activity (MTT) was assessed. Measurement of GSH with the fluorescent indicator MCB-monochlorobimane indicated that in SeMet preincubated C6 cells, MeHg treatment resulted in a significant (p < 0.001) decrease in GSH levels as compared to coincubation group. Treatment with SeMet did not induce any significant changes in MTT activity in either of the cell lines as compared to the MeHg group. However, the amount of MeHg-induced ROS was significantly reduced (p < 0.001) after SeMet preincubation in both the cell lines. The intracellular Se content was measured with high resolution-inductively coupled plasma mass spectrometry (HR-ICPMS). In both the cell lines the intracellular Se levels increased after pre- and coincubation with 20 and 50 μM SeMet. However, the preincubation group exhibited increased Se content in both the cell lines and varied (p < 0.001) from coincubation group. These differences in the Se content were maintained after 10 μM MeHg treatment for 50 min. In C6-gliomas, the cell associated-MeHg measurements using 14C-labeled MeHg indicated a significant increase (p < 0.001) in MeHg content in preincubated cells as compared to coincubated cells. These findings provide experimental evidence that preincubation with SeMet increases Se content in cells and prevents against increased MeHg-induced ROS generation.

KW - Cell cultures

KW - In vitro

KW - Neurotoxicity

KW - Reactive oxygen species

KW - Reduced glutathione

KW - Selenomethionine

UR - http://www.scopus.com/inward/record.url?scp=60549086210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549086210&partnerID=8YFLogxK

U2 - 10.1016/j.tiv.2008.12.024

DO - 10.1016/j.tiv.2008.12.024

M3 - Article

C2 - 19168124

AN - SCOPUS:60549086210

VL - 23

SP - 378

EP - 385

JO - Toxicology in Vitro

JF - Toxicology in Vitro

SN - 0887-2333

IS - 3

ER -